Languages: German, English, French

Dr. med. Dr. rer. nat. Elisabeth Roider is a Swiss (FMH) and European (FEBDV) specialist in dermatology and venereology with a special focus on holistic aesthetic and regenerative medicine. She combines classic procedures such as Botox, fillers, biostimulators, thread lifts and lasers with scientifically based methods of regenerative medicine and longevity medicine.

As a physician-scientist, she heads an international laboratory at the University of Basel and Harvard Medical School.

Special areas of expertise:

• Holistic aesthetic dermatology
• Regenerative Medicine & Longevity Medicine
• Surgical Dermatology
• Complex conservative dermatology

Memberships:

• Swiss Society for Dermatology and Venereology
• European Academy of Dermatology and Venereology (EADV)
• Fellow of the European Board of Dermatology and Venereology (FEBDV)
• Healthy Longevity Medicine Society

Publications (selection):

• Roider E et al., Scientific Reports , 2024: MITF regulates IDH1 and NNT and drives a transcriptional program protecting cutaneous melanoma from reactive oxygen species. DOI: 10.1038/s41598-024-21527-w
• Maul LV, Jamiolkowski D, Roider E et al., JAMA Network Open , 2024: Health Economic Consequences of Delayed Melanoma Diagnosis due to COVID-19 Pandemic in Europe. DOI: 10.1001/jamanetworkopen.2023.56479
• Roider E, Fisher DE, Cell , 2021: NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism. DOI: 10.1016/j.cell.2021.06.043
• Roider E et al., The Lancet , 2020: SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report. DOI: 10.1016/S0140-6736(20)31791-0

Further publications available upon request or via PubMed.